A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
<p>Abstract</p> <p>Background</p> <p>Olanzapine rapid-acting intramuscular (IM) injection is an atypical antipsychotic drug already used overseas and recently approved in Japan. The objective of this study was to confirm the efficacy of rapid-acting IM olanzapine 10 mg...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-244X/13/20 |